It’s J.P. Morgan time — so all biopharma eyes will be attuned to the dallyings and dealings taking place this week in the hallowed halls of San Francisco’s Westin St. Francis. Of course, there are plenty of ancillary events going on (like the Biotech Showcase — which has become nearly as popular), so here’s what we’re watching out for in the worlds of pharma and biotech:

The J.P. Morgan Healthcare Conference

Well, yeah. Plenty of illuminating sessions to come during the premier biopharma event of the year. Standout sessions on Monday include Illumina, Biogen, and NantHealth. On Tuesday? We’re particularly curious about what Sarepta, Axovant, Juno Therapeutics, and especially Valeant Pharmaceuticals have to say for themselves. The past year’s been rife with news — and some controversy — from these companies.

Unlock this article by subscribing to STAT Plus today. Try it FREE for 30 days and cancel anytime!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.

Privacy Policy